Florian von der Muelbe
Gründer bei CureVac SE
Profil
Florian von der Muelbe is the founder of CureVac SE and CureVac NV, both founded in 2000.
He holds the title of Chief Production Officer at CureVac SE from 2018 to present.
He also held the title of Chief Production Officer at CureVac NV from 2015 to 2021.
Dr. von der Muelbe is currently a Co-Managing Director at CureVac Real Estate GmbH since 2017.
He previously worked as a Principal at Biotest AG.
Dr. von der Muelbe holds a doctorate from Eberhard Karls Universität Tübingen and an MBA from ESB Business School.
Aktive Positionen von Florian von der Muelbe
| Unternehmen | Position | Beginn |
|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Gründer | 01.01.2000 |
CureVac Real Estate GmbH
 CureVac Real Estate GmbH Real Estate DevelopmentFinance CureVac Real Estate GmbH manages commercial and non-residential buildings. The company is headquartered in Tuebingen, Germany. | Vorstandsvorsitzender | 01.02.2017 |
Ehemalige bekannte Positionen von Florian von der Muelbe
| Unternehmen | Position | Ende |
|---|---|---|
| CUREVAC N.V. | Gründer | 01.07.2021 |
| BIOTEST AG | Corporate Officer/Principal | - |
Ausbildung von Florian von der Muelbe
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| ESB Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOTEST AG | Health Technology |
| CUREVAC N.V. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
CureVac Real Estate GmbH
CureVac Real Estate GmbH Real Estate DevelopmentFinance CureVac Real Estate GmbH manages commercial and non-residential buildings. The company is headquartered in Tuebingen, Germany. | Finance |
